OASM Key Statistics, Chart & Performance
The current stock price of OASM is 1.55 null. In the past month the price decreased by -15.35%. In the past year, price decreased by -13.89%.
OASM Latest News, Press Relases and Analysis
About OASM
Company Profile
Oasmia Pharmaceutical AB is a pharmaceutical company which develops and manufactures drugs for human and veterinary oncology. Its drugs portfolio comprises Paclical, Doxophos, Docecal and OAS-19, for human treatment as well as Paccal Vet-CA1 and Doxophos Vet, for cancer treatment in dogs, which are in different clinical phases. Oasmia Pharmaceutical AB is based in Uppsala, Sweden.
Company Info
Oasmia Pharmaceutical Ab
VALLONGATAN 1
UPPSALA V7 75228
CEO: Mikael Asp
Phone: 461-850-5440
Oasmia Pharmaceutical Ab / OASM FAQ
Can you describe the business of Oasmia Pharmaceutical Ab?
Oasmia Pharmaceutical AB is a pharmaceutical company which develops and manufactures drugs for human and veterinary oncology. Its drugs portfolio comprises Paclical, Doxophos, Docecal and OAS-19, for human treatment as well as Paccal Vet-CA1 and Doxophos Vet, for cancer treatment in dogs, which are in different clinical phases. Oasmia Pharmaceutical AB is based in Uppsala, Sweden.
What is the stock price of Oasmia Pharmaceutical Ab today?
The current stock price of OASM is 1.55 null. The price increased by 1.97% in the last trading session.
Does Oasmia Pharmaceutical Ab pay dividends?
OASM does not pay a dividend.
What is the ChartMill technical and fundamental rating of OASM stock?
OASM has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists OASM stock?
OASM stock is listed on the Nasdaq exchange.
What is the ownership structure of Oasmia Pharmaceutical Ab (OASM)?
You can find the ownership structure of Oasmia Pharmaceutical Ab (OASM) on the Ownership tab.
OASM Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to OASM. When comparing the yearly performance of all stocks, OASM is a bad performer in the overall market: 65.76% of all stocks are doing better.
OASM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to OASM. Both the profitability and financial health of OASM have multiple concerns.
OASM Financial Highlights
Over the last trailing twelve months OASM reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS decreased by -11.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -8636.74% | ||
| ROA | -30.36% | ||
| ROE | -42.79% | ||
| Debt/Equity | 0 |